Table 2.
Baseline characteristics
| Characteristic | Value |
|---|---|
| Total patients, n | 12 |
| Female/male | 10/2 |
| Age, years | |
| Median (min-max) | 50.5 (27–77) |
| Subtype, n | |
| ETR | 3 |
| ETR + PPR | 9 |
| DLQI score, 0–30 points | |
| Median (min-max) | 2.5 (1–6) |
| Baseline medians for both face sides | Control | Treated | p value (control vs. treated) |
|---|---|---|---|
| IGA score, 0–4 grades | 3 | 3 | 0.6 |
| Lesion count, n | 7 | 6 | 0.3 |
| Intensity of skin redness Δα | 13.0 | 11.9 | 0.5 |
| Erythema size, cm2 | 10.3 | 11.7 | 0.1 |
DLQI, Dermatology Life Quality Index; ETR, erythemato-telangiectatic rosacea; IGA, Investigator Global Assessment; PPR, papulopustular rosacea.
p value <0.05 was considered as statistically significant.